Pages that link to "Q409455"
Jump to navigation
Jump to search
The following pages link to ibogaine (Q409455):
Displayed 50 items.
- Tabernanthe iboga (Q132677) (← links)
- Tabernaemontana undulata (Q2386501) (← links)
- Voacanga africana (Q4015906) (← links)
- Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption (Q24530154) (← links)
- Ibogaine-associated cardiac arrest and death: case report and review of the literature (Q26747731) (← links)
- Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca (Q26781223) (← links)
- The anti-addiction drug ibogaine and the heart: a delicate relation (Q27009689) (← links)
- Autoregulation of glial cell line-derived neurotrophic factor expression: implications for the long-lasting actions of the anti-addiction drug, Ibogaine (Q28267147) (← links)
- Mechanisms of antiaddictive actions of ibogaine (Q28276843) (← links)
- The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex (Q28287426) (← links)
- Ervayunine: a new indole alkaloid from Ervatamia yunnanensis (Q28293010) (← links)
- Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration (Q28297349) (← links)
- Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor (Q28318844) (← links)
- Ibogaine alters synaptosomal and glial glutamate release and uptake. (Q32037211) (← links)
- Noribogaine generalization to the ibogaine stimulus: correlation with noribogaine concentration in rat brain. (Q33865853) (← links)
- Treatment of acute opioid withdrawal with ibogaine (Q33875759) (← links)
- Pharmacokinetic characterization of the indole alkaloid ibogaine in rats (Q33905325) (← links)
- Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures (Q33925738) (← links)
- In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats (Q33942467) (← links)
- Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener (Q33955956) (← links)
- Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine (Q34101436) (← links)
- Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats (Q34170650) (← links)
- N-(Hydroxymethyl)ibogaine (Q34227184) (← links)
- Fatalities temporally associated with the ingestion of ibogaine (Q34249047) (← links)
- Radioligand-binding study of noribogaine, a likely metabolite of ibogaine (Q34314313) (← links)
- Ibogaine in the treatment of substance dependence (Q34341800) (← links)
- Inhibitory effects of ibogaine on cocaine self-administration in rats (Q34344843) (← links)
- Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline (Q34354909) (← links)
- Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats (Q34369825) (← links)
- Ibogaine produces neurodegeneration in rat, but not mouse, cerebellum. Neurohistological biomarkers of Purkinje cell loss (Q34410645) (← links)
- Ibogaine: a review (Q34435889) (← links)
- Characterization of multiple sites of action of ibogaine (Q34435896) (← links)
- Changes in gene expression and signal transduction following ibogaine treatment (Q34435906) (← links)
- Ibogaine in the treatment of heroin withdrawal (Q34435912) (← links)
- Ibogaine neurotoxicity assessment: electrophysiological, neurochemical, and neurohistological methods (Q34435923) (← links)
- Modulation of the effects of rewarding drugs by ibogaine (Q34435931) (← links)
- Ibogaine as a glutamate antagonist: relevance to its putative antiaddictive properties (Q34435949) (← links)
- Drug discrimination studies with ibogaine (Q34435958) (← links)
- Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections (Q34558401) (← links)
- Distribution of ibogaine and noribogaine in a man following a poisoning involving root bark of the Tabernanthe iboga shrub (Q34564340) (← links)
- Interaction of ibogaine with human alpha3beta4-nicotinic acetylcholine receptors in different conformational states. (Q34660170) (← links)
- Ibogaine and the inhibition of acetylcholinesterase (Q34660637) (← links)
- The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters (Q34660686) (← links)
- Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk (Q34660694) (← links)
- Life-threatening complications of ibogaine: three case reports (Q34660895) (← links)
- The ibogaine medical subculture (Q34716139) (← links)
- Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation (Q34726525) (← links)
- Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine (Q34756084) (← links)
- Effects and aftereffects of ibogaine on morphine self-administration in rats (Q34805866) (← links)
- Acute toxicity of ibogaine and noribogaine. (Q34921106) (← links)